Second‐stage treatments for relative nonresponders to cognitive behavioral therapy (cbt) for panic disorder with or without agoraphobia—continued cbt versus ssri: a randomized controlled trial
ConclusionsThese data suggest greater improvement in panic disorder symptoms when switching to SSRI after failure to fully respond to an initial course of CBT. Future studies should further investigate relapse following treatment discontinuation for nonresponders who became responders. Clinicaltrials.gov Identifier: NCT00000368; https://clinicaltrials.gov/show/NCT00000368
Source: Depression and Anxiety - Category: Psychiatry Authors: Laura A. Payne, Kamila S. White, Matthew W. Gallagher, Scott W. Woods, M. Katherine Shear, Jack M. Gorman, Todd J. Farchione, David H. Barlow Tags: Research Article Source Type: research
More News: Anxiety | Celexa | Citalopram | Depression | Panic Disorder | Paroxetine | Paxil | Psychiatry | Study